Here are our plans. This year we have upped the challenge, taking on the Dublin Mountain’s Way in a Day ⛰ We will hike through the Dublin Mountains from Tallaght to Glencullen, and maybe even all the way to Shankill on September 25th! Our challenge is not only to do #DMW in a Day & support three wonderful charities CMRF Crumlin/National Children’s Research Centre, Neuroblastoma UK and the Conor Foley Neuroblastoma Cancer Research Foundation but also beat our past fundraising records! If we raise 2K+, we’ll do 30km in a day. If 3K+ then 42km! Can u challenge us? All funds raised will go to the 3 selected charities. Every donation big or small is hugely appreciated!
Every 100th cancer patient is a child. Cancer is the 2nd most common cause of death among children after accidents.
Childhood cancer is an umbrella term for many other types of this disease. Every September, many charities, researchers and parents of children with cancer work hard to raise awareness of this cancer. You may learn more about kids with cancer, their loving families, the doctors and caregivers who looking after them and treating them, the young survivors of cancer and those kids and teens who lost their battle, and the scientists who working hard to find a way to stop childhood cancer.
This year our research team will hike Dublin MountainWay in One Day on the 25th of September 2021 whatever the weather in honour of Childhood Cancer Awareness Month. For every one euro donated to research only 1 cent of this goes to ALL childhood health conditions including cancer. Therefore, the donations we receive will be split equally among some wonderful children’s charities. These charities include the Conor Foley Neuroblastoma Research Foundation (CFNRF), Neuroblastoma UK (NBUK), Children’s Research & Medical Foundation (CRMF) Crumlin.
If you would like to get involved in this amazing challenge and help us raise vital funds for childhood cancers, you can contribute to our fundraising page:
We will work closely with the Conor Foley Neuroblastoma Cancer Research Foundation – a research charity led by the family who lost their child to neuroblastoma. An inspirational example of never giving up.
We will continue to dissect neuroblastoma biology using innovative platforms such as tumour-on-chip and 3D scaffold-based models in collaboration with our colleagues in the Tissue Engineering Research Group at RCSI and the Fraunhofer Project Centre at DCU.
This announcement is timely to celebrate Childhood Cancer Awareness Month in September.
Two talented and dedicated young scientists are joining our team. In 4 years time, we will have another pic of their graduation on the same stairs.
The new norm, new challenges, new excitement and new achievements! We all proud to say that we completed 10K Vhi Womens Mini marathon socially distanced. Our paces were so different that distancing came absolutely natural. We ran it individually but were a team mentally. Even the capricious Irish weather was our ally. The Sun was bright. The air was fresh and crispy.
This was an individual challenge #POWEROF10: just you and the trail. 10 laps around St Stephen’s Green park were to make the target 10K in aid of Childhood Cancer Awareness Month. The celebration of life, therapeutical advancements, the strength of little patients battling their cancer and their families, doctors and carers who are supporting them in their journey. The emphasis on the gaps in available treatments and diagnosis and the importance of research that needs funding.
Personally, my 10K were split into two parts. The first 4K were full of arguments with my body. Why didn’t I like to do laps? Could I complete 10K? Was I fit to do it? Keep going! No walking – better slow jogging. Did one lap make 1K? Should I do a longer lap instead? And so on and so forth. Then, the second part kicked in. My body stopped arguing and began to enjoy it. I noticed beautiful Autumn colours on the trees, people walking around with a cup of coffee or chatting away, saw my team members overtaking me, and our volunteers counting our laps. People on the street and in the park were cheering us up. What a wonderful and fulfilling day!
As Catherine says: “The 10 Laps 10km challenge was tough! Like many people, I took up running casually during the lockdown, however, I never did more than a couple of kilometres at once, so I was absolutely not prepared for running 10. But the cheers from our socially distanced spectators and all the online support we received meant I got through it. Also knowing what a positive impact this challenge could have for the future of childhood cancer treatment provided plenty of motivation to finish the race 💛🎗”
10K by 6 team members socially distanced. #POWEROF10. Go Gold! Let’s reach 1.5k in donations!
Our Go Fund Me page is still open until this Sunday (October 11th midnight) if you wish to support us.
Our team is expanding – we are welcome our new PhD student Ellen King!Her project will add another dimension to neuroblastoma research. She will look into potential targets on the surface of neuroblastoma cells resistant to therapy and investigate how we can strengthen the patient immune systemresponse.
Like everyone, my current workspace looks very different from what it normally looks like. I have just joined the Cancer Bioengineering Group as a PhD student in the midst of the pandemic. Certain moments like induction day or meeting my new lab mates, will all be done virtually due to the pandemic. Luckily, I have spent the last year working as a research assistant at RCSI and this has taken away all the stresses of finding my way around a new campus and indeed making friends. Without a doubt, the transition is and will be a strange one but the excitement and enthusiasm haven’t gone anywhere!
Recently, my days as a researcher have been spent at my lovely, newly-built (with the help of IKEA instructions) home desk. And as the picture I have standing proudly beside my laptop says, there really is no place like home. I feel very lucky to be able to safely work from home and continue my research while so many people are now without jobs or are risking their lives to keep people safe during the pandemic.
“NÍL AON TINTEÁN MAR DO THINTEÁN FÉIN” – THERE IS NO FIRESIDE LIKE YOUR OWN
Most days I wake up early and go for a run along the lovely canal beside my house. This is a great way to wake up my brain and is also great preparation for our virtual VHI mini-marathon on the 7th of October 2020 in honour of Childhood Cancer Awareness Month. I start work at around 9am, which at the moment is mostly research, reading papers and writing a literature review in preparation for my return to the lab soon. I miss the experimental side of my research and am really excited to start this new exciting project.
This summer, I had an amazing opportunity to work under the supervision of Dr. Olga Piskareva. I scheduled to join the lab for the second time, however, this plan was unfortunately cancelled to the COVID19. I was still hopeful and later I got the opportunity to work on a remote research project. My goal was to write a comprehensive review of existing and prospective antigens for antibody specific immunotherapy for neuroblastoma.
This was my first literature review and I was excited about it. I had previously worked on a lab neuroblastoma project that’s why I was familiar with the topic. However, this was a completely new and different undertaking for me. Before starting the project I had to understand about literature reviews are and how are they written. My project involved looking at a lots of clinical trials and PubMed articles. I had to learn about how clinical trials work and had to develop a search strategy for the project. I understood that literature reviews are a very important part of lab research and forms its backbone.
Sanat’s review focussed on antibody-based immunotherapy in neuroblastoma, which aims to induce ‘antibody-dependent cellular cytotoxicity’ to kill cancer cells. Luckily, Sanat had wet lab research experience in 2019 pre-COVID where he got to present a research project at the Matrix Biology Ireland meeting.
I started writing the project and ended up writing 40 pages! I developed awesome illustrations to support my review using the software. This was one of the most enjoyable parts of the remote research! As I was writing the project I understood that ‘Neuroblastoma is a devasting disease for children and the tremendous amount of effort and knowledge is being built upon to find a better and enhanced treatment to reduce the disease burden.’
I learnt and gained many critical skills during this review. My review on the existing and prospective knowledge about immunotherapies will enable researchers to get a summary of knowledge that will aid in giving them direction to eventually, create effective immunotherapy to defeat neuroblastoma.
Sanat Rashinkar, 3rd Year RCSI Undergraduate Medicine Student
This year our research team will be taking part in the virtual VHI mini-marathon on the 7th of October 2020 in honour of Childhood Cancer Awareness Month. For every one euro donated to research only 1 cent of this goes to ALL childhood health conditions including cancer. Therefore, the donations we receive will be split equally among some wonderful children’s charities. These charities include: The Conor Foley Neuroblastoma Research Foundation (CFNRF), Neuroblastoma UK (NBUK), Children’s Research & Medical Foundation (CRMF) CrumlinIf you would like to get involved in this amazing virtual event and help us raise vital funds for childhood cancers, attached is a link where you can register to the event: https://www.vhiwomensminimarathon.ie/power-of-10.
Our team is very appreciative of the support we get from these charities. We would be very grateful if you could help support our virtual marathon challenge by making a donation to these wonderful charities in light of childhood cancer awareness month.
Last year we managed to raise an amazing 1750 euro taking part in the 8km Hell and Back challenge. We are eager to surpass that target this year. All donations no matter how small are appreciated: https://www.gofundme.com/f/c7dkeu-childhood-cancer-awarness-month
You may wonder whether I re-submit the same. the third time? Actually, our team has 3 ongoing PhD students and one starting from October. So, here we are. Three identical titles so far but different journeys. Today, it is Tom’s turn to tell his story.
Three years I ago I decided to try my hand at some cancer research and quit my job as a medical scientist in a diagnostic lab. I am now in my third year of a PhD and I am certain I made the right choice. It was a challenging transition from working in an environment with a lot of automation and standard operating procedures to one where you have to figure out everything for yourself! However, I think that that learning experience has allowed me to adjust quite well to all of the COVID-19 related upheaval.
Pre-pandemic you could saunter between your office and the lab as often as you pleased, you had a choice of at least four different places to go for coffee on campus and you could squeeze into a packed lift to avoid the stairs to the lab. Now a day in the lab is quite different. We have to book lab space online, social distance from our colleagues, frequent hand washing and wear a mask at all times.
Tom Frawley
These days I plan all my lab work and book lab bench space the week before. On a typical day I split my time between the lab and working from home. I am quite fortunate that my commute is only a 6 minute walk through Stephens Green, which is only 5 minutes longer than the walk from the lab to my old office.
Working through a pandemic is certainly challenging however I do appreciate my time in the lab much more now and I feel like I am much more productive when access to the lab is limited.
A lot has changed for me since I began my research journey in RCSI, as I transitioned from being an undergraduate placement student to a PhD candidate, however the biggest change has been adjusting to doing a lab-based PhD during a pandemic!
We wear red coats when looking after our rather large family of neuroblastoma cells, which happily grow inside the 37°C incubator. White coats are for most other lab work, such as analysing proteins by gel electrophoresis and Western blotting. And of course, the newest lab accessory – the facemask.
These days my work hours are shared between the labs in RCSI and my family home. While my bench space and office space used to be separated by just a few steps, there is now a 30+ minute bus journey between them. It has certainly put my planning skills to the test as now when I walk into the lab I need to be sure of what I am planning to do, and that I can complete the task in my pre-booked lab time slot.
I appreciate my time in the labs much more now that I spend so much time at home. Whether I am culturing neuroblastoma cells, analyzing proteins or genes by Western blots or PCRs, I enjoy immersing myself in the work knowing that my time on the bench is limited.
The main perk is that now when I am doing computer work – analyzing results, writing reviews, preparing presentations, using online software – I can do it from the comfort of my box-room-office, often very cosy in a blanket as I do it. While my work-from-home desk space is slightly more spacious than my desk in the now-closed “Write-up Room 2”, I do miss the chats and laughs that come with working in a shared office.
My WFH set-up. My new office buddies don’t quite understand the need for personal space.
One thing’s for sure though, my two dogs very much enjoy the days that I work from home!
Catherine Murphy, Neuroblastoma UK funded PhD student
This summer I worked under Dr Piskareva supervision in the remote research program. My original plans for a lab experience were put down by COVID. My ultimate goal was to write the review article on the potential uses of retinoic acid in neuroblastoma research.
Nadiya Bayeva
Before starting the project, I didn’t have any specific expectations. While I always had fun picking the primary articles apart and summarising the gathered data during my undergrad and med school, I didn’t believe that this experience would be the special one. And I kept thinking so as I was collecting the information from the numerous data on cell cultures. And as I was looking at the mice models studies. And clinical trials.
Then I started to write my introduction, and so researched the information on the neuroblastoma prognosis, contemporary treatment protocol and outcomes. And suddenly I saw my project in the new light. I was used to regarding the clinical trials outcomes as simple statistics, but this time no desensitization could shield me. Yes, 60% of the patients in the high-risk group die in 5 years after diagnosis, and yes, 90% of those patients are children less than 5 years old. And there is nothing that we could currently do to save those children.
On the other hand, this realisation brought meaning to my work. This time, I was not doing a PubMed search to get a good mark or CV reference. Instead, I was looking for the possible treatment of the disease. My review on the current knowledge about retinoic acid will let the other primary researchers target the most promising drug for future experiments and, eventually, create a novel and effective therapy to help those children.
And isn’t it what we are all striving for in medical research?
